Gilead shows its belief in its partner’s cancer treatment with a $7.8 billion buyout
Arcellx’s stock is heading toward a record after the $7.8 billion deal to be acquired by Gilead. View Source Tomi Kilgore MarketWatch.com – Top Stories…
Arcellx’s stock is heading toward a record after the $7.8 billion deal to be acquired by Gilead. View Source Tomi Kilgore MarketWatch.com – Top Stories…
A booming AI economy may be very bad for the broader economy, according to Citrini Research View Source Jamie Chisholm MarketWatch.com – Top Stories February…
“Within a week or two after the deadline to contest the will expired, my stepmother sent me an email stating she would not share anything.”…
Vertiv has been a top holding among hedge and mutual funds in the first quarter of this year so far, and a lucrative one. View…
Novo Nordisk shares were under pressure on Monday as the struggling Danish pharmaceutical said a head-to-head study found a drug in development didn’t cut as…
“I own a home worth $520,000 and do not have a mortgage on it.” View Source Quentin Fottrell MarketWatch.com – Top Stories February 23, 2026…
Decent growth, benign inflation, a dovish Fed and a weaker dollar all favor equities but international and emerging stocks look set to build on the…
Novo Nordisk shares were under pressure on Monday as the struggling Danish pharmaceutical said a head-to-head study found a drug in development didn’t cut as…
Justin Trudeau has forked over $3.1 million for an expansive estate in Montreal’s exclusive Outremont neighborhood—and got the seal of approval from girlfriend Katy Perry.…
View Source Most popular articles February 23, 2026 3:01 am